Staff Directory
Academic Qualification
- PhD in Pharmaceutical Science Research - Doctor of Philosophy, King's College London
- Bachelor of Engineering - Bachelor Degree, Kobe University
Izzat Fahimuddin Bin Mohamed Suffian (Dr.)
Assistant Professor
IIUM Kuantan Campus
KULLIYYAH OF PHARMACY
izzat_fahimuddin@iium.edu.my
3054
Expert Profile
Dr. Izzat Fahimuddin Bin Mohamed Suffian joined Kulliyyah of Pharmacy as a lecturer in November 2016. He is currently an Assistant Professor in Drug Delivery and Nanomedicine. He was awarded the Look East Policy Programme Scholarship from the Public Service Department, Government of Malaysia (2006-2012) to complete his first degree in Bachelor of Engineering in Chemical Science and Engineering at the Department of Chemical Science and Engineering, Faculty of Engineering, Kobe University (Japan). He worked briefly as a research assistant at the Biochemical Engineering Laboratory, Kobe University where he focussed on studying the role of arginine in the arginine-rich domain of Hepatitis B Virus core particles on cell uptake using in vitro models. He was also awarded the Excellent Student Programme (PPC) Scholarship from Public Service Department, Government of Malaysia (2012-2016) to complete his PhD in Pharmacology and Pharmaceutical and Analytical Science from King’s College London, United Kingdom, which involves engineering targeted hepatitis B virus core particles for cancer therapy. During his PhD studies, Dr. Izzat was awarded the prestigious Wellcome Image Awards, which recognise the creators of the most informative, striking and technically excellent images that communicate significant aspects of biomedical science in 2014 and 2016. As well as being a previous Wellcome Image Award winner, he has also won a science photography competition organised by the Engineering and Physical Sciences Research Council (EPSRC) in 2014. He has developed an extensive experience in designing and developing novel nanoscale delivery systems including virus-like particles and liposomes. His current work involves pre-clinical translation of novel nanomaterials designed specifically for drug, siRNA, plasmid and radionuclide delivery for therapeutic or diagnostic applications. He reported the potential of Hepatitis B Virus core particles as nanocarriers in targeting HER2-positive metastatic abdominal cancer following intra-peritoneal administration in vivo. In 2020, Izzat has been selected as a fellow with other 52 among 300 academics from all over public universities in Malaysia, under a programme called CEO@Faculty Programme 2.0 Cycle 3. This programme is organised by Ministry of Education, aimed at exposing university lecturers below 40 years old with a doctoral degree to the rudiments and operations of the industry. The programme celebrates the CEOs who have voluntarily accepted the task to coach young university lecturers to become future leaders. Currently, Izzat is attached with Datuk Nora A. Manaf, Chief Group Human Capital, Maybank Group Berhad, under this programme.
Area of Specialisation
- Medical And Health ~ Medical And Health Sciences ~ Biomedical Sciences ~ Nanomedicine - Drug delivery
Professional Membership
- 2019 - 2020: Member of Profesional Body / Association: (Co-opted Exco Member), The Malaysia Local Chapter of the Controlled Release Society (MyCRS)
Teaching Responsibilities
| COSMETICS & COSMECEUTICALS | 2022/2023 |
| Drug Abuse | 2017/2018 |
| FINAL YEAR RESEARCH PROJECT | 2022/2023 |
| IMMUNOLOGY | 2019/2020 2018/2019 2017/2018 |
| NUCLEAR PHARMACY | 2022/2023 2020/2021 2019/2020 2018/2019 2017/2018 |
| PHARMACEUTICAL BIOTECHNOLOGY & BIOPHARMACEUTICAL | 2021/2022 |
| PHARMACEUTICAL MICROBIOLOGY | 2018/2019 2017/2018 2016/2017 |
| RESEARCH PROJECT 1 | 2021/2022 2020/2021 2019/2020 2018/2019 2017/2018 |
| RESEARCH PROJECT 2 | 2021/2022 2020/2021 2019/2020 2018/2019 |
| RESEARCH PROJECT-LITERATURE SEARCH | 2020/2021 2019/2020 2018/2019 |
| STERILE PROCESSES AND PRODUCTS | 2022/2023 2021/2022 |
Research Projects
Completed
| 2019 - 2023 | Assessment on suitable hydrocolloids for probiotic encapsulation enhancing its viablity and stability |
| 2018 - 2020 | In vitro effect of Tamarindus indica as a potential anti-larvae of screwworm maggots obtained from goats with myiasis |
| 2017 - 2022 | Rheological and Physical Properties characterization of nanoparticles-hydrogel for topical oral drug of oral cancer (targeted drug delivery) |
On-Going
| 2021 - Present | Optimisation, Assembly, Testing, Validation, and Scaling Up of the Nanotech COVID19 Rapid Test Kit |
| 2021 - Present | Hepatotoxicity Studies of Eltrombopag-Loaded PLGA_PEG polymeric Nanocapsules in ITP-Induced Mice Model |
| 2019 - Present | Preparation, characterisation and cytotoxicity assay of damnacanthal-loaded polymeric nanocapsules for breast cancer therapy |
| 2017 - Present | Formulation of 5-Fluorouracil-loaded EGFR-Targeted Hydrogel-Nanocapsule Hybrids for Oral Squamous Cell Carcinoma Therapy |
Award & Recognition
| 02 May, 2017 | Best Paper Presentation - ASIA International Multidisciplinary Conference 2017 | International |
Publications
Article
Conference or Workshop Item
| 2021 | Angiotensin-converting enzyme inhibition activity and LCMS analysis of Syzygium polyanthum (Wight) Walp leaves. In: National Symposium on Essential Oils, Plants, Cosmetic and Health, |
| 2021 | Mechanism of angiotensin converting enzyme (ACE) inhibition by Syzygium polyanthum wight (WALP.) leaves. In: IIUM Research Day 2021: An International Online Event for Life Sciences, |
| 2021 | Molecular binding interaction of angiotensin converting enzyme and 1-galloyl glucose, the major compound in Syzygium polyanthum leaves. In: 7th International Conference on Advancement in Science and Technology (iCAST2021), |
Book Section
| 2021 | In vitro angiotensin-converting enzyme (ACE) inhibition activity of Syzygium polyanthum leaves and its inhibition mechanism. In: Frontiers, ISBN: 978-2-88971-008-9, pp. |